
About Jammi Pharmaceuticals Private Limited
Data last updated:
Jammi Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 02 May 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U85310TN2018PTC122433. Its GSTIN is 33AAECJ2471R1Z6 (Tamil Nadu).
The company has an authorised share capital of ₹35 Lakh and a paid-up capital of ₹32.06 Lakh. It is led by directors Narasimham V Jammi and Anitha Balachander.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Chennai, Tamil Nadu.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.45 Cr, a growth of 59% compared to the previous year. For the same year it recorded a net profit of ₹11.7 Lakh (net margin 2.6%) and EBITDA of ₹35.53 Lakh (EBITDA margin 8%). Revenue has grown at a compounded annual rate (CAGR) of 29% over three years and 36% over five years.
The company has about 42 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Jammi. As per MCA filings, the company has open charges of ₹1.7 Cr and satisfied charges of ₹80.5 Lakh on record. Court records list 3 cases involving the company, including 3 filed by the company.
Jammi Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0036263). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website jammi.in.
Company details
Recognitions & Rankings of Jammi Pharmaceuticals
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-02-0036263
Contact details
Jammi Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its website is jammi.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressAbhirami Apartments, Old No 20 New No 14 Flat No 2B 2nd Floor Dr Nair Road T Nagar, Chennai, Tamil Nadu, India – 600017
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Jammi Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Jammi Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Jammi Pharmaceuticals Private Limited, buy the company report.
Financials of Jammi Pharmaceuticals Private Limited
FY 2025 filings availableJammi Pharmaceuticals Private Limited reported revenue of ₹4.45 Cr (up 59% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 36% over five years, including 59% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹4.45 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹35.53 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11.7 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8% | ||||
| Net Profit Margin | 2.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Jammi Pharmaceuticals Private Limited, buy the company report.
Board of directors of Jammi Pharmaceuticals Private Limited
Jammi Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Narasimham V Jammi | Director | 02 May 2018 | 8 Years 6 Months | Current |
| Anitha Balachander | Additional Director | 07 Jul 2021 | 5 Years 4 Months | Current |
Auditor
Jammi Pharmaceuticals Private Limited is audited by SHUBHADRA & AJIT for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHUBHADRA & AJIT | FY 2023 | 012151S |
Shareholding
The shareholding of Jammi Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Jammi Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Sep 2025 | 101169769 | Bank of India | ₹1.7 Cr | Open | |
| 10 Aug 2022 | 100610298 | Others | ₹80.5 Lakh | Satisfied |
To see the full charge records of Jammi Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Jammi Pharmaceuticals Private Limited has 3 court cases on record: 3 filed by Jammi Pharmaceuticals. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 0 | 0 |
Cases on record (2 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Madras High Court | Writ petition | Filed by the company against an individual | Disposed |
| Madras High Court | Interim or miscellaneous application | Filed by the company against an individual | Disposed |
To see the full case history of Jammi Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Jammi Pharmaceuticals Private Limited has 2 MSME Form 1 returns on record between 2019 and 2020, listing 5 overdue payments to 3 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (3 of 3)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Parle Tableting Technologies Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Jammi Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Jammi Pharmaceuticals Private Limited has a workforce of 42 employees on its EPFO records as of Jun 2023, across 3 active EPFO establishments.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2023-24 | 42 |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Jammi Pharmaceuticals Private Limited, buy the company report.
GST
Jammi Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAECJ2471R1Z6 | Tamil Nadu | Active | 08 Jun 2018 |
To see the full GST registrations and return filing status of Jammi Pharmaceuticals Private Limited, buy the company report.
Recent activity
Jammi Pharmaceuticals Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Jammi Venkata Butchi Lakshmirama Narasu ceased to be Director on 08 Jul 2025.
Frequently asked questions
Jammi Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 02 May 2018 (8+ years old) and is registered under CIN U85310TN2018PTC122433.
Jammi Pharmaceuticals has 2 current directors:
- Narasimham V Jammi - Director
- Anitha Balachander - Additional Director
The latest financial statements of Jammi Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Jammi Pharmaceuticals is 33AAECJ2471R1Z6, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Jammi Pharmaceuticals is U85310TN2018PTC122433. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jammi Pharmaceuticals has 3 court cases on record: 3 filed by the company.
Jammi Pharmaceuticals was incorporated on 02 May 2018, making it 8+ years old. It is registered with the Registrar of Companies, Chennai.
Jammi Venkata Butchi Lakshmirama Narasu ceased to be Director on 08 Jul 2025. Anitha Balachander was appointed as Additional Director on 07 Jul 2021. Narasimham V Jammi was appointed as Director on 02 May 2018.
Yes, Jammi Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Jammi Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-02-0036263).
Jammi Pharmaceuticals has 2 MSME Form 1 returns on record between 2019 and 2020, listing 5 overdue payments to 3 micro and small suppliers. The latest return was filed on 31 Dec 2020.

